Binxian Wei serves as Independent Director of the Company. He has been the V.P. of Darsheng Trade & Tech. Development Co, Ltd. (a subsidiary to Tianjin Tiayo Pharmaceutical Co., Ltd.) since 2015. He is responsible for API and finished dosage marketing for Chinese pharmaceutical companies. From 2008 through 2010, he worked as a business development manager for Sakai Trading. He holds a Master’s degree in Mathematical & Computer Sciences from Colorado School of Mines, a Master’s Degree and Bachelor’s Degree in Chemical Engineering from Tianjin University in China. Bin-Xian Wei was appointed as the director representative of the Series A 4.5% Convertible Preferred Stock by Tianjin Pharmaceuticals Group International Holdings Co., LTD, the sole holder of the outstanding Series A 4.5% Convertible Preferred Stock.
Binxian Wei is 49, he's been the Independent Director of Seneca Biopharma Inc since 2019. There are 12 older and no younger executives at Seneca Biopharma Inc. The oldest executive at Seneca Biopharma Inc is Stanley Westreich, 81, who is the Independent Director.
Binxian's mailing address filed with the SEC is 20271 GOLDENROD LANE, 2ND FLOOR, , GERMANTOWN, MD, 20876.
Seneca Biopharma Inc executives and other stock owners filed with the SEC include: